We report a patient with recurrent breast cancer with multiple pulmonary and hepatic metastases treated with two different CDK4/6 inhibitors, who achieved a CR and is disease free to this day, 6 years after the first recurrence. This evidence concerns the gene CDK4 and breast cancer.